First, NMO-IgG has been observed to access the brain from the blood (blood-CNS barrier) through fenestrated endothelial cells in circumventricular organs such as the area postrema where AQP4 protein is highly expressed [2,3]. This evidence concerns the gene AQP4 and neuromyelitis optica.